Applied Biosystems announces the global option of its 3500 Series Genetic Analyzer Applied Biosystems, part of Lifestyle Technologies Corporation , today announced the global industrial availability of a fresh capillary electrophoresis sequencing system. The 3500 Series Genetic Analyzer is for research use only not intended for therapeutic or diagnostic make use of . Since May 2009, more than 10 research institutions have been participating in an early on evaluation of the technology with main interest in learning the most more popular human genetic disorders, such as those caused by lacking or extra chromosomes, in addition to a broad spectral range of other diseases. C. Camargo, Brazil; Transcriptome Research Group, National Institute of Radiological Sciences, Japan; and University of Tokyo, Japan.

on line pharmacy

Related StoriesTIS physicians selected as recipients of D Magazine 2015 Greatest Doctors in DallasResearchers examine how small wireless sensors integrated into orthopedic implants can help identify SSIBiodegradable polymer may help heal the bones of individuals with orthopedic injuriesApixaban is a novel, oral, selective Factor Xa inhibitor extremely, a fresh class of agents getting studied for the potential to prevent and treat bloodstream clots in the veins and arteries.. Application for regulatory authorization of apixaban in European countries to be submitted Bristol-Myers Squibb Organization and Pfizer today announced that the firms are planning to fill out an application for regulatory authorization of apixaban in Europe for preventing venous thromboembolism after orthopedic surgery in the first fifty % of 2010.